Using Basic Ethical Principles to Evaluate Safety Efforts in Transfusion Medicine
Pursuit of pharmaceutical purity of the blood in the bag has led to a shrinking donor base and a significantly more expensive product. Decisions regarding new infectious marker testing and donor deferrals have typically been made emphasizing decreasing one specific risk without considering the effec...
Gespeichert in:
Veröffentlicht in: | Journal of blood transfusion 2012, Vol.2012 (2012), p.1-6 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6 |
---|---|
container_issue | 2012 |
container_start_page | 1 |
container_title | Journal of blood transfusion |
container_volume | 2012 |
creator | Brooks, Jay P. |
description | Pursuit of pharmaceutical purity of the blood in the bag has led to a shrinking donor base and a significantly more expensive product. Decisions regarding new infectious marker testing and donor deferrals have typically been made emphasizing decreasing one specific risk without considering the effect the intervention will have on the overall safety and availability of blood transfusion. Regulations have been formulated by governmental agencies with limited input from the medical community. The decision making process has lacked risk benefit analyses and has not had the robustness associated with spirited discussions. Policies made in this manner may result in certain risks being decreased but can also have adverse unintended consequences. Being guided by the ethical principles of nonmaleficence, beneficence, autonomy, and justice, we need to evaluate our actions in the context of overall blood safety rather than narrowly focusing on any one area. |
doi_str_mv | 10.1155/2012/407326 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3777255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>24089647</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2416-14e4be6611c4db21841bc2b41855749bc682c0c25cae28e83b1dd10d2af45c823</originalsourceid><addsrcrecordid>eNqFkM9LwzAUx4MobsydPCs5K9Ukza9eBB31B0xU3M4hTdMt0qWj6Sb77-2oFj35Lu_B-7zPgy8ApxhdYczYNUGYXFMkYsIPwJCgBEUJTthhP0sxAOMQPlBbgiKSxMdgQCiSCadiCN7mwfkFvNPBGZg2S2d0CV9r541blzbApoLpVpcb3Vj4rgvb7GBaFFXdBOg8nNXah2ITXOXhs82dcd6egKNCl8GOv_sIzO_T2eQxmr48PE1up5EhFPMIU0szyznGhuYZwZLizJCMYsmYoElmuCQGGcKMtkRaGWc4zzHKiS4oM5LEI3DTedebbGVzY31T61Kta7fS9U5V2qm_G--WalFtVSyEIIy1gstOYOoqhNoW_S1Gah-u2oerunBb-vz3u579ibIFLjpg6XyuP90_trMOti1iC93DlCdckPgLe1mLeQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Using Basic Ethical Principles to Evaluate Safety Efforts in Transfusion Medicine</title><source>PubMed Central(OpenAccess)</source><source>Wiley_OA刊</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Brooks, Jay P.</creator><contributor>van den Burg, Peter J. M.</contributor><creatorcontrib>Brooks, Jay P. ; van den Burg, Peter J. M.</creatorcontrib><description>Pursuit of pharmaceutical purity of the blood in the bag has led to a shrinking donor base and a significantly more expensive product. Decisions regarding new infectious marker testing and donor deferrals have typically been made emphasizing decreasing one specific risk without considering the effect the intervention will have on the overall safety and availability of blood transfusion. Regulations have been formulated by governmental agencies with limited input from the medical community. The decision making process has lacked risk benefit analyses and has not had the robustness associated with spirited discussions. Policies made in this manner may result in certain risks being decreased but can also have adverse unintended consequences. Being guided by the ethical principles of nonmaleficence, beneficence, autonomy, and justice, we need to evaluate our actions in the context of overall blood safety rather than narrowly focusing on any one area.</description><identifier>ISSN: 2090-9187</identifier><identifier>EISSN: 2090-9195</identifier><identifier>DOI: 10.1155/2012/407326</identifier><identifier>PMID: 24089647</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Puplishing Corporation</publisher><subject>Review</subject><ispartof>Journal of blood transfusion, 2012, Vol.2012 (2012), p.1-6</ispartof><rights>Copyright © 2012 Jay P. Brooks.</rights><rights>Copyright © 2012 Jay P. Brooks. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2416-14e4be6611c4db21841bc2b41855749bc682c0c25cae28e83b1dd10d2af45c823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777255/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777255/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,27923,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24089647$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>van den Burg, Peter J. M.</contributor><creatorcontrib>Brooks, Jay P.</creatorcontrib><title>Using Basic Ethical Principles to Evaluate Safety Efforts in Transfusion Medicine</title><title>Journal of blood transfusion</title><addtitle>J Blood Transfus</addtitle><description>Pursuit of pharmaceutical purity of the blood in the bag has led to a shrinking donor base and a significantly more expensive product. Decisions regarding new infectious marker testing and donor deferrals have typically been made emphasizing decreasing one specific risk without considering the effect the intervention will have on the overall safety and availability of blood transfusion. Regulations have been formulated by governmental agencies with limited input from the medical community. The decision making process has lacked risk benefit analyses and has not had the robustness associated with spirited discussions. Policies made in this manner may result in certain risks being decreased but can also have adverse unintended consequences. Being guided by the ethical principles of nonmaleficence, beneficence, autonomy, and justice, we need to evaluate our actions in the context of overall blood safety rather than narrowly focusing on any one area.</description><subject>Review</subject><issn>2090-9187</issn><issn>2090-9195</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><recordid>eNqFkM9LwzAUx4MobsydPCs5K9Ukza9eBB31B0xU3M4hTdMt0qWj6Sb77-2oFj35Lu_B-7zPgy8ApxhdYczYNUGYXFMkYsIPwJCgBEUJTthhP0sxAOMQPlBbgiKSxMdgQCiSCadiCN7mwfkFvNPBGZg2S2d0CV9r541blzbApoLpVpcb3Vj4rgvb7GBaFFXdBOg8nNXah2ITXOXhs82dcd6egKNCl8GOv_sIzO_T2eQxmr48PE1up5EhFPMIU0szyznGhuYZwZLizJCMYsmYoElmuCQGGcKMtkRaGWc4zzHKiS4oM5LEI3DTedebbGVzY31T61Kta7fS9U5V2qm_G--WalFtVSyEIIy1gstOYOoqhNoW_S1Gah-u2oerunBb-vz3u579ibIFLjpg6XyuP90_trMOti1iC93DlCdckPgLe1mLeQ</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>Brooks, Jay P.</creator><general>Hindawi Puplishing Corporation</general><general>Hindawi Publishing Corporation</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>2012</creationdate><title>Using Basic Ethical Principles to Evaluate Safety Efforts in Transfusion Medicine</title><author>Brooks, Jay P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2416-14e4be6611c4db21841bc2b41855749bc682c0c25cae28e83b1dd10d2af45c823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brooks, Jay P.</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of blood transfusion</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brooks, Jay P.</au><au>van den Burg, Peter J. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Using Basic Ethical Principles to Evaluate Safety Efforts in Transfusion Medicine</atitle><jtitle>Journal of blood transfusion</jtitle><addtitle>J Blood Transfus</addtitle><date>2012</date><risdate>2012</risdate><volume>2012</volume><issue>2012</issue><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>2090-9187</issn><eissn>2090-9195</eissn><abstract>Pursuit of pharmaceutical purity of the blood in the bag has led to a shrinking donor base and a significantly more expensive product. Decisions regarding new infectious marker testing and donor deferrals have typically been made emphasizing decreasing one specific risk without considering the effect the intervention will have on the overall safety and availability of blood transfusion. Regulations have been formulated by governmental agencies with limited input from the medical community. The decision making process has lacked risk benefit analyses and has not had the robustness associated with spirited discussions. Policies made in this manner may result in certain risks being decreased but can also have adverse unintended consequences. Being guided by the ethical principles of nonmaleficence, beneficence, autonomy, and justice, we need to evaluate our actions in the context of overall blood safety rather than narrowly focusing on any one area.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Puplishing Corporation</pub><pmid>24089647</pmid><doi>10.1155/2012/407326</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2090-9187 |
ispartof | Journal of blood transfusion, 2012, Vol.2012 (2012), p.1-6 |
issn | 2090-9187 2090-9195 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3777255 |
source | PubMed Central(OpenAccess); Wiley_OA刊; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection; PubMed Central Open Access |
subjects | Review |
title | Using Basic Ethical Principles to Evaluate Safety Efforts in Transfusion Medicine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T10%3A25%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Using%20Basic%20Ethical%20Principles%20to%20Evaluate%20Safety%20Efforts%20in%20Transfusion%20Medicine&rft.jtitle=Journal%20of%20blood%20transfusion&rft.au=Brooks,%20Jay%20P.&rft.date=2012&rft.volume=2012&rft.issue=2012&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=2090-9187&rft.eissn=2090-9195&rft_id=info:doi/10.1155/2012/407326&rft_dat=%3Cpubmed_cross%3E24089647%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/24089647&rfr_iscdi=true |